Income Statement Tibet Duo Rui Pharmaceutical Co., Ltd.

Stocks

301075

CNE100004RW5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 26/06/2026			5-day change	1st Jan Change
59.21 ^CNY	-6.87%		-11.77%	-0.77%

04-28	Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-23	Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

0d18ef.hRJbJdFYjYs0chzp7V0fihuizIKHOazD7Y9SYWHFLs4.ymQzXeAQoMh7FHSbty9QyEmSm8e3FJ-01cRhGDCaep_qSjoT52zr5XswWQ

Published financial data: TIBET DUO RUI PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	530M	401M	334M	240M	154M
Other Revenues, Total	-	68.64K	632K	709K	-
Total Revenues	530M	401M	334M	241M	154M
Cost of Goods Sold, Total	60.43M	92.68M	106M	149M	142M
Gross Profit	469M	308M	228M	91.8M	12.6M
Selling General & Admin Expenses, Total	375M	273M	202M	135M	79.99M
Provision for Bad Debts	1.36M	2.7M	-965K	5.64M	-
R&D Expenses	24.07M	26.45M	24M	37M	32.41M
Other Operating Expenses	6.59M	4.64M	3.7M	1.93M	-5.29M
Other Operating Expenses, Total	407M	307M	229M	180M	107M
Operating Income	62.38M	1.81M	-746K	-87.81M	-94.52M
Interest Expense, Total	-1.18M	-1.36M	-3.11M	-7.9M	-
Interest And Investment Income	1.16M	9.3M	13.36M	10.07M	853K
Net Interest Expenses	-14.79K	7.94M	10.25M	2.17M	853K
Other Non Operating Income (Expenses)	-72.92K	-204K	-55.6K	-1.74M	-31.64M
EBT, Excl. Unusual Items	62.3M	9.55M	9.44M	-87.39M	-125M
Impairment of Goodwill	-	-	-3.27K	-234K	-
Gain (Loss) On Sale Of Investments	-196K	-	66K	542K	38.58K
Gain (Loss) On Sale Of Assets	-	-	82.89K	43.53K	-105K
Asset Writedown	-625	-6.05K	-8.3K	-45.28K	-5.99M
Insurance Settlements	-	-	-	-	-
Other Unusual Items	11.18M	11.48M	12.67M	1.31M	-
EBT, Incl. Unusual Items	73.28M	21.02M	22.25M	-85.77M	-131M
Income Tax Expense	7.42M	2.44M	5.16M	-746K	1.04M
Earnings From Continuing Operations	65.86M	18.58M	17.09M	-85.03M	-132M
Net Income to Company	65.86M	18.58M	17.09M	-85.03M	-132M
Minority Interest	2.65M	1.92M	1.76M	22.36M	30.23M
Net Income - (IS)	68.51M	20.5M	18.85M	-62.67M	-102M
Net Income to Common Incl Extra Items	68.51M	20.5M	18.85M	-62.67M	-102M
Net Income to Common Excl. Extra Items	68.51M	20.5M	18.85M	-62.67M	-102M
Per Share Items
Net EPS - Basic	1.05	0.26	0.24	-0.79	-1.29
Basic EPS - Continuing Operations	1.05	0.26	0.24	-0.79	-1.29
Basic Weighted Average Shares Outstanding	65.25M	78.85M	78.54M	79.32M	79.2M
Net EPS - Diluted	1.05	0.26	0.24	-0.79	-1.29
Diluted EPS - Continuing Operations	1.05	0.26	0.24	-0.79	-1.29
Diluted Weighted Average Shares Outstanding	65.25M	78.85M	78.54M	79.32M	79.2M
Normalized Basic EPS	0.64	0.1	0.1	-0.41	-0.61
Normalized Diluted EPS	0.64	0.1	0.1	-0.41	-0.61
Dividend Per Share	0.62	-	0.12	-	-
Payout Ratio	1.68	247.95	17.26	-27.25	-8.6
Supplemental Items
EBITDA	76.06M	16.37M	17.37M	-61.1M	-45.36M
EBITA	62.84M	2.33M	-90.88K	-86.77M	-92.32M
EBIT	62.38M	1.81M	-746K	-87.81M	-94.52M
EBITDAR	78.96M	19.65M	20.51M	-59.12M	-
Total Revenues (As Reported)	530M	401M	334M	241M	-
Effective Tax Rate - (Ratio)	10.12	11.61	23.18	0.87	-0.79
Current Domestic Taxes	7.53M	2.57M	5.74M	1.58M	-
Total Current Taxes	7.53M	2.57M	5.74M	1.58M	-
Deferred Domestic Taxes	-117K	-125K	-580K	-2.33M	-
Total Deferred Taxes	-117K	-125K	-580K	-2.33M	-
Normalized Net Income	41.58M	7.89M	7.66M	-32.26M	-48.08M
Interest on Long-Term Debt	75.75K	61.28K	35.64K	235K	-
Supplemental Operating Expense Items
Advertising Expense	315M	218M	146M	62.61M	-
Selling and Marketing Expenses	325M	230M	161M	80.7M	23.1M
General and Administrative Expenses	47.22M	40.21M	38.93M	53.54M	56.9M
Research And Development Expense From Footnotes	24.07M	26.45M	24M	37M	32.41M
Net Rental Expense, Total	2.9M	3.28M	3.14M	1.97M	-
Imputed Operating Lease Interest Expense	986K	587K	556K	347K	-
Imputed Operating Lease Depreciation	1.92M	2.7M	2.58M	1.63M	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	611M	426M	405M	262M	85.28M
Trading Asset Securities, Total	-	80M	77.56M	142M	20.04M
Total Cash And Short Term Investments	611M	506M	483M	404M	105M
Accounts Receivable, Total	100M	92.3M	85.51M	108M	87.89M
Other Receivables	2.28M	7.88M	11.2M	19.55M	17.09M
Total Receivables	103M	100M	96.7M	127M	105M
Inventory	9.82M	32.77M	33.13M	45.85M	83.54M
Prepaid Expenses	56.35K	56.35K	47.52K	1.26K	-
Other Current Assets, Total	5.64M	8.66M	36.23M	53.61M	35.23M
Total Current Assets	729M	647M	649M	631M	329M
Gross Property Plant And Equipment	166M	187M	305M	778M	-
Accumulated Depreciation	-63M	-75.95M	-94.79M	-125M	-
Net Property Plant And Equipment	103M	111M	210M	653M	695M
Long-term Investments	-	113M	155M	108M	111M
Goodwill	-	-	3.69M	19.22M	18.7M
Other Intangibles, Total	16.85M	21.24M	34.19M	78.48M	76.64M
Deferred Tax Assets Long-Term	653K	779K	1.25M	3.09M	3.49M
Deferred Charges Long-Term	1.46M	327K	2.7M	2.84M	2.01M
Other Long-Term Assets, Total	-	5.8M	16.33M	39.64M	47.8M
Total Assets	851M	899M	1.07B	1.53B	1.28B
Liabilities
Accounts Payable, Total	23.01M	12.13M	26.77M	58.14M	77.29M
Accrued Expenses, Total	10.46M	13.09M	8.58M	9M	7.25M
Short-term Borrowings	20M	100M	50.13M	276M	67.76M
Current Portion of Long-Term Debt	-	-	11.01M	115M	110M
Current Portion of Leases	476K	291K	596K	3.03M	-
Current Income Taxes Payable	2.87M	1.35M	2.41M	1.26M	392K
Unearned Revenue Current, Total	3.72M	4.16M	5.08M	2.78M	7.55M
Other Current Liabilities	2.25M	13.49M	24.6M	44.41M	172M
Total Current Liabilities	62.79M	145M	129M	509M	442M
Long-Term Debt	-	-	118M	138M	88.5M
Long-Term Leases	-	882K	306K	7.21M	3.73M
Unearned Revenue Non Current	-	-	2.12M	107M	105M
Deferred Tax Liability Non Current	-	-	902K	20.54M	20.29M
Total Liabilities	62.79M	145M	251M	782M	660M
Common Stock, Total	80M	80M	80M	80M	80M
Additional Paid In Capital	521M	510M	509M	507M	507M
Retained Earnings	192M	163M	182M	110M	7.47M
Treasury Stock	-	-	-	-20.99M	-20.99M
Comprehensive Income and Other	-	-1.3M	676K	1.14M	1.14M
Total Common Equity	793M	752M	772M	677M	575M
Minority Interest	-4.28M	1.89M	49.61M	76.74M	49.03M
Total Equity	789M	753M	822M	753M	624M
Total Liabilities And Equity	851M	899M	1.07B	1.53B	1.28B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	80M	80M	80M	78.96M	79.14M
ECS Total Common Shares Outstanding	80M	80M	80M	78.96M	79.14M
Book Value / Share	9.91	9.39	9.65	8.57	7.26
Tangible Book Value	776M	730M	734M	579M	479M
Tangible Book Value Per Share	9.7	9.13	9.18	7.33	6.05
Total Debt	20.48M	101M	180M	538M	270M
Net Debt	-590M	-405M	-303M	135M	165M
Debt Equivalent Oper. Leases	23.23M	26.28M	25.11M	15.78M	-
Minority Interest, Total (Incl. Fin. Div)	-4.28M	1.89M	49.61M	76.74M	49.03M
Equity Method Investments, Total	-	82.92M	85.75M	29.84M	-
Account Code - Inventory Valuation	5	5	5	5	-
Inventories - Raw Materials, Total	5M	6.51M	10.65M	12.15M	-
Inventories - Work In Process, Total	-	-	2.51M	7.62M	-
Inventories - Finished Goods, Total	4.92M	26.62M	21.06M	37.96M	-
Buildings, Total	164M	117M	168M	507M	-
Machinery, Total	-	63.47M	126M	251M	-
Full Time Employees	299	318	395	484	-
Accumulated Allowance for Doubtful Accounts (Supple)	6.06M	6.88M	7.26M	12.9M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	68.51M	20.5M	18.85M	-62.67M	-132M
Depreciation & Amortization - CF	14.35M	15.17M	18.05M	28.22M	50.12M
Amortization of Goodwill and Intangible Assets - (CF)	454K	516K	655K	1.04M	2.19M
Depreciation & Amortization, Total	14.8M	15.69M	18.7M	29.26M	52.31M
Amortization of Deferred Charges, Total - (CF)	1.13M	1.2M	588K	475K	319K
(Gain) Loss From Sale Of Asset	-	-	-82.89K	-43.53K	105K
(Gain) Loss on Sale of Investments - (CF)	-181K	-299K	-5.65M	-5.33M	-853K
Asset Writedown & Restructuring Costs	1.45M	3.07M	39.5K	-262K	6.78M
Provision and Write-off of Bad Debts	-	-	-	5.64M	-
Other Operating Activities, Total	-1.47M	-3.98M	-2.34M	-5.76M	29.78M
Change In Accounts Receivable	6.57M	-4.87M	-12.99M	-32.38M	16.29M
Change In Inventories	4.91M	-23.31M	2.91M	-18.95M	-43.51M
Change In Accounts Payable	-47.45M	-6.75M	-7.15M	25.17M	26M
Change In Deferred Taxes	-117K	-125K	-461K	-2.33M	-647K
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	48.15M	1.13M	12.41M	-67.18M	-45.83M
Capital Expenditure	-5.35M	-32.73M	-23.69M	-40.92M	-102M
Sale of Property, Plant, and Equipment	-	8K	573K	-	776K
Cash Acquisitions	-	-	-35.09M	-47.99M	-
Divestitures	-	-	537K	60M	8.8M
Investment in Marketable and Equity Securities, Total	0	-185M	-45.31M	-167M	109M
Other Investing Activities, Total	-110M	14.87M	34.6M	3.58M	156M
Cash from Investing	-115M	-203M	-68.38M	-192M	173M
Short Term Debt Issued, Total	50M	100M	-	1.9M	-
Long-Term Debt Issued, Total	-	-	230M	168M	128M
Total Debt Issued	50M	100M	230M	170M	128M
Short Term Debt Repaid, Total	-65M	-20M	-156M	-	-
Long-Term Debt Repaid, Total	-	-	-	-112M	-184M
Total Debt Repaid	-65M	-20M	-156M	-112M	-184M
Issuance of Common Stock	508M	-	-	-	-
Repurchase of Common Stock	-	-	-	-20.99M	-
Common Dividends Paid	-1.15M	-50.84M	-3.25M	-17.08M	-8.79M
Common & Preferred Stock Dividends Paid	-1.15M	-50.84M	-3.25M	-17.08M	-8.79M
Other Financing Activities, Total	-48.36M	15.87M	-9.97M	20.72M	-86.59M
Cash from Financing	443M	45.04M	60.87M	40.64M	-152M
Foreign Exchange Rate Adjustments	-	-	-	-	-1.46K
Net Change in Cash	376M	-157M	4.91M	-219M	-24.84M
Supplemental Items
Cash Income Tax Paid (Refund)	67.14M	39.32M	38.3M	17.8M	8.82M
Levered Free Cash Flow	11.76M	-37.18M	-8.03M	-83.69M	43.37M
Unlevered Free Cash Flow	12.5M	-36.33M	-6.08M	-78.75M	43.37M
Change In Net Working Capital	37.07M	21.64M	1.22M	12.69M	-152M
Net Debt Issued / Repaid	-15M	80M	74.1M	57.99M	-56.21M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.38	0.13	-0.05	-4.21	-4.19
Return on Total Capital	7.19	0.14	-0.05	-4.79	-5.4
Return On Equity %	12.8	2.41	2.17	-10.8	-19.23
Return on Common Equity	13.23	2.65	2.47	-8.65	-16.33
Margin Analysis
Gross Profit Margin %	88.59	76.89	68.24	38.15	8.17
SG&A Margin	70.77	68.01	60.46	56.12	51.89
EBITDA Margin %	14.36	4.08	5.2	-25.39	-29.42
EBITA Margin %	11.86	0.58	-0.03	-36.06	-59.88
EBIT Margin %	11.78	0.45	-0.22	-36.49	-61.3
Income From Continuing Operations Margin %	12.44	4.63	5.11	-35.33	-85.88
Net Income Margin %	12.94	5.11	5.64	-26.04	-66.27
Net Avail. For Common Margin %	12.94	5.11	5.64	-26.04	-66.27
Normalized Net Income Margin	7.85	1.97	2.29	-13.41	-31.18
Levered Free Cash Flow Margin	2.22	-9.27	-2.4	-34.78	28.13
Unlevered Free Cash Flow Margin	2.36	-9.06	-1.82	-32.73	28.13
Asset Turnover
Asset Turnover	0.87	0.46	0.34	0.18	0.11
Fixed Assets Turnover	4.91	3.75	2.09	0.56	0.23
Receivables Turnover (Average Receivables)	5.17	4.16	3.75	2.48	1.57
Inventory Turnover (Average Inventory)	4.9	4.35	3.22	3.77	2.19
Short Term Liquidity
Current Ratio	11.61	4.48	5.02	1.24	0.74
Quick Ratio	11.36	4.19	4.49	1.04	0.48
Operating Cash Flow to Current Liabilities	0.77	0.01	0.1	-0.13	-0.1
Days Sales Outstanding (Average Receivables)	70.63	87.67	97.25	147.55	231.81
Days Outstanding Inventory (Average Inventory)	74.45	83.87	113.25	97.11	166.79
Average Days Payable Outstanding	291.38	55.46	66.61	96.18	137.87
Cash Conversion Cycle (Average Days)	-146.3	116.08	143.89	148.49	260.73
Long Term Solvency
Total Debt/Equity	2.6	13.44	21.92	71.47	43.36
Total Debt / Total Capital	2.53	11.85	17.98	41.68	30.24
LT Debt/Equity	-	0.12	14.41	19.21	14.79
Long-Term Debt / Total Capital	-	0.1	11.82	11.2	10.32
Total Liabilities / Total Assets	7.37	16.18	23.37	50.91	51.41
EBIT / Interest Expense	52.93	1.33	-0.24	-11.12	-
EBITDA / Interest Expense	65.48	12.87	5.77	-7.41	-
(EBITDA - Capex) / Interest Expense	60.95	-11.19	-1.84	-12.59	-
Total Debt / EBITDA	0.27	5.78	10.03	-9.2	-6.23
Net Debt / EBITDA	-7.65	-23.11	-16.86	-2.3	-3.8
Total Debt / (EBITDA - Capex)	0.29	-6.65	-31.43	-5.41	-1.86
Net Debt / (EBITDA - Capex)	-8.22	26.57	52.82	-1.35	-1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.05	-24.28	-16.64	-28.02	-35.93
Gross Profit, 1 Yr. Growth %	5.28	-34.28	-26.03	-59.75	-86.27
EBITDA, 1 Yr. Growth %	-2.41	-78.48	5.65	-487.74	-25.76
EBITA, 1 Yr. Growth %	-5.16	-96.29	-103.78	4.99K	6.39
EBIT, 1 Yr. Growth %	-5.2	-97.09	-141.15	3.32K	7.63
Earnings From Cont. Operations, 1 Yr. Growth %	-26.51	-71.78	-8.03	-597.46	55.72
Net Income, 1 Yr. Growth %	-25.53	-70.07	-8.05	-432.44	63.04
Normalized Net Income, 1 Yr. Growth %	-1.17	-81.03	-2.84	-522.88	49.05
Diluted EPS Before Extra, 1 Yr. Growth %	-31.37	-75.24	-7.69	-429.17	63.29
Accounts Receivable, 1 Yr. Growth %	-4.12	-8	-7.36	26.24	-18.57
Inventory, 1 Yr. Growth %	-33.75	233.55	1.1	38.4	82.21
Net Property, Plant and Equip., 1 Yr. Growth %	-7.77	7.03	89.56	211.15	6.39
Total Assets, 1 Yr. Growth %	129.49	5.57	19.29	43.15	-16.4
Tangible Book Value, 1 Yr. Growth %	244.85	-5.9	0.53	-21.13	-17.25
Common Equity, 1 Yr. Growth %	227.16	-5.22	2.73	-12.35	-15.1
Cash From Operations, 1 Yr. Growth %	-24.34	-97.66	1K	-641.19	-31.77
Capital Expenditures, 1 Yr. Growth %	-89.48	512.19	-27.61	72.72	148.85
Levered Free Cash Flow, 1 Yr. Growth %	-127.62	-416.15	-78.41	812.78	-151.83
Unlevered Free Cash Flow, 1 Yr. Growth %	-130.22	-390.71	-83.26	990.25	-155.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.56	-9.55	-20.55	-22.54	-32.09
Gross Profit, 2 Yr. CAGR %	4.91	-16.82	-30.27	-45.44	-76.5
EBITDA, 2 Yr. CAGR %	5.55	-54.18	-52.21	92.76	69.67
EBITA, 2 Yr. CAGR %	3.3	-81.25	-96.2	500.69	635.73
EBIT, 2 Yr. CAGR %	3.26	-83.4	-89.07	596.07	506.44
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.77	-54.46	-49.06	113.9	178.33
Net Income, 2 Yr. CAGR %	-2.26	-52.79	-47.54	74.83	132.81
Normalized Net Income, 2 Yr. CAGR %	7.66	-56.71	-57.07	102.25	151.06
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-58.78	-52.19	74.31	131.84
Accounts Receivable, 2 Yr. CAGR %	5.72	-6.08	-7.68	8.14	1.39
Inventory, 2 Yr. CAGR %	21.25	48.66	83.63	18.29	58.8
Net Property, Plant and Equip., 2 Yr. CAGR %	14.7	-0.64	42.44	142.86	81.94
Total Assets, 2 Yr. CAGR %	70.1	55.65	12.22	30.68	9.4
Tangible Book Value, 2 Yr. CAGR %	137.49	80.14	-2.74	-10.96	-19.21
Common Equity, 2 Yr. CAGR %	129.63	76.09	-1.32	-5.11	-13.74
Cash From Operations, 2 Yr. CAGR %	16.83	-86.69	-49.23	672.19	92.15
Capital Expenditures, 2 Yr. CAGR %	-35.07	-19.76	110.51	11.81	107.32
Levered Free Cash Flow, 2 Yr. CAGR %	-14.73	-6.56	-17.38	50.02	117.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.08	-6.27	-30.24	47.22	145.05
Dividend Per Share, 2 Yr. CAGR %	-	-	-55.28	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.93	-3.73	-11.98	-23.12	-27.29
Gross Profit, 3 Yr. CAGR %	12.47	-10.24	-20.01	-41.94	-65.56
EBITDA, 3 Yr. CAGR %	8.75	-37.88	-39.37	-7.04	40.25
EBITA, 3 Yr. CAGR %	5.53	-65.93	-88.89	11.35	237.34
EBIT, 3 Yr. CAGR %	5.54	-68.59	-77.54	12.07	273.61
Earnings From Cont. Operations, 3 Yr. CAGR %	16.05	-36.07	-42.44	8.89	92.42
Net Income, 3 Yr. CAGR %	16.5	-34.12	-41.04	-2.93	70.81
Normalized Net Income, 3 Yr. CAGR %	7.53	-39.65	-43.32	-8.12	82.68
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-46.07	-9.05	70.56
Accounts Receivable, 3 Yr. CAGR %	4.16	0.94	-6.51	2.47	-1.62
Inventory, 3 Yr. CAGR %	6.96	69.89	30.73	67.11	36.61
Net Property, Plant and Equip., 3 Yr. CAGR %	10.52	12.08	23.23	84.82	84.45
Total Assets, 3 Yr. CAGR %	53.65	45.1	42.44	21.71	12.6
Tangible Book Value, 3 Yr. CAGR %	133.35	74.43	48.31	-9.3	-13.1
Common Equity, 3 Yr. CAGR %	120.25	70.97	47.14	-5.14	-8.56
Cash From Operations, 3 Yr. CAGR %	-9.73	-68.27	-42.01	11.74	243.93
Capital Expenditures, 3 Yr. CAGR %	-29.24	37.17	-22.47	97.07	45.99
Levered Free Cash Flow, 3 Yr. CAGR %	-	31.97	-42.66	92.34	5.27
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	34.93	-47.21	84.7	6.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-0.85	-11.75	-20.65
Gross Profit, 5 Yr. CAGR %	-	-	-7.11	-26.44	-50.99
EBITDA, 5 Yr. CAGR %	-	-	-21.73	-2.2	-10.26
EBITA, 5 Yr. CAGR %	-	-	-72.07	8.06	6.86
EBIT, 5 Yr. CAGR %	-	-	-57.39	8.46	7.51
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-16.51	3.63	8.12
Net Income, 5 Yr. CAGR %	-	-	-15.33	-2.66	2.12
Normalized Net Income, 5 Yr. CAGR %	-	-	-25.52	-2.1	3.9
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-3.35
Accounts Receivable, 5 Yr. CAGR %	-	-	-0.75	3.76	-3.43
Inventory, 5 Yr. CAGR %	-	-	32.78	46.98	41.31
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	22.33	52.71	44.01
Total Assets, 5 Yr. CAGR %	-	-	35.5	39.15	28.17
Tangible Book Value, 5 Yr. CAGR %	-	-	64.43	33.3	16.32
Common Equity, 5 Yr. CAGR %	-	-	59.75	35.1	18.84
Cash From Operations, 5 Yr. CAGR %	-	-	-28.29	13.75	-6.35
Capital Expenditures, 5 Yr. CAGR %	-	-	9.45	26.4	14.91
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	38.91	0.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	39.72	0.96